Twitter Youtube



In 2020, in Europe, there were
58,169 cervical cancer cases
and 25,989 deaths.

Incidence and mortality rates vary widely across
Europe, with age-standardized incidence rates
ranging from less than 5 cases per 100,000 women
to above 25 cases per 100,000 women and
age-standardised mortality rates from 1
death per 100,000 women to 10
deaths per 100,000 women.
HPV vaccination coverages vary
considerably across Europe
Cervical cancer can be prevented by the HPV
vaccination, however HPV vaccination coverages
vary considerably across Europe from less
than 5% to more than 90%.
18 European countries and 34
partner organisations working
together to increase HPV vaccination coverage
specially in regions with low coverage and to
optimize data collection to monitor HPV vaccination
coverage and the impact of vaccination.



In 2020, in Europe, there were
58,169 cervical cancer cases
and 25,989 deaths.

Incidence and mortality rates vary widely across
Europe, with age-standardized incidence rates
ranging from less than 5 cases per 100,000 women
to above 25 cases per 100,000 women and
age-standardised mortality rates from 1
death per 100,000 women to 10
deaths per 100,000 women.
HPV vaccination coverages vary
considerably across Europe
Cervical cancer can be prevented by the HPV
vaccination, however HPV vaccination coverages
vary considerably across Europe from less
than 5% to more than 90%.
18 European countries and 34
partner organisations working
together to increase HPV vaccination coverage
specially in regions with low coverage and to
optimize data collection to monitor HPV vaccination
coverage and the impact of vaccination.

About PERCH

PERCH Kick – OFF Meeting – December 2022 – Brussels

Project PERCH brings together 18 European countries and 34 partner organizations with the objective of contributing to the implementation of Europe’s Beating Cancer Plan. PERCH aligns with the World Health Organization’s (WHO) “90-70-90” strategy, aiming to achieve at least 90% HPV vaccination coverage among girls, and potentially boys, by the age of 15 years.

Project objectives are:

  • Improve capacities of Member States to plan and implement HPV vaccination campaigns by sharing knowledge and experience.
  • Improve data and monitoring system on HPV vaccination and HPV screening.
  • Improve knowledge and awareness on HPV-related disease and prevention in specific target groups (adolescent girls and boys).
  • Improve knowledge and abilities for healthcare professionals in HPV vaccine communication.

NEWS & EVENTS

SOCIAL MEDIA

TWITTER chanell

Newsletter subscrition

Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV

SUBSCRIBE NEWSLETTER

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

Cookie Preferences

Cookie Policy

Privacy Policy

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

Cookie Preferences Cookie Policy Privacy Policy